Cargando…
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598426/ https://www.ncbi.nlm.nih.gov/pubmed/31293978 http://dx.doi.org/10.3389/fonc.2019.00551 |
| _version_ | 1783430771521880064 |
|---|---|
| author | Brooks, Eric D. Verma, Vivek Chang, Joe Y. |
| author_facet | Brooks, Eric D. Verma, Vivek Chang, Joe Y. |
| author_sort | Brooks, Eric D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6598426 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65984262019-07-10 Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? Brooks, Eric D. Verma, Vivek Chang, Joe Y. Front Oncol Oncology Frontiers Media S.A. 2019-06-21 /pmc/articles/PMC6598426/ /pubmed/31293978 http://dx.doi.org/10.3389/fonc.2019.00551 Text en Copyright © 2019 Brooks, Verma and Chang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Brooks, Eric D. Verma, Vivek Chang, Joe Y. Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
| title | Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
| title_full | Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
| title_fullStr | Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
| title_full_unstemmed | Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
| title_short | Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
| title_sort | does pathologic response equate to clinical response following sabr for early-stage nsclc? |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598426/ https://www.ncbi.nlm.nih.gov/pubmed/31293978 http://dx.doi.org/10.3389/fonc.2019.00551 |
| work_keys_str_mv | AT brooksericd doespathologicresponseequatetoclinicalresponsefollowingsabrforearlystagensclc AT vermavivek doespathologicresponseequatetoclinicalresponsefollowingsabrforearlystagensclc AT changjoey doespathologicresponseequatetoclinicalresponsefollowingsabrforearlystagensclc |